Health Canada clears QBKPN to enter clinic to restore innate immunity in elderly
July 21, 2022
Qu Biologics has received clearance from Health Canada to proceed with a randomized, placebo-controlled trial of QBKPN, a first-in-class innate immune modulator that enhances lung immunity, in the elderly.